EVAX Evaxion A/S American Depositary Share Biological Products, (No Diagnostic Substances) Best Biotech Stocks 2026 →

Evaxion A/S (EVAX) Stock: Buy, Sell, or Hold?

$2.77
-0.14 (-4.81%) â–ŧ
5d: +0.36% 30d: -1.07% 90d: -17.07%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (80%)
Quality Score
45/100
Position
SLIGHTLY LOW
30-Day Fair Range
$2.76 – $3.41
Position: SLIGHTLY LOW
Forward P/E & Valuation
-184.7x CHEAP
vs 83.6x historical avg
Wall Street Target
$12.25
+342.2% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$2.67 / $3.21
Trend: Sideways
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
â„šī¸ NEUTRAL: EVAX is fairly priced but lacks strong directional signals. At 0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.

Get Alerted When EVAX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: EVAX is currently trading at $2.77, which is considered slightly low relative to its 30-day fair value range of $2.76 to $3.41. From a valuation perspective, the stock is trading at a discount (Forward PE: -184.7) compared to its historical average (83.6). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, EVAX is showing sideways momentum. Immediate support is located at $2.67, while resistance sits at $3.21. Short-term momentum is weak, with the stock down 4.8% recently.

Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $12.25 (+342.2%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position SLIGHTLY LOW
Historical Trading Range $2.76 - $3.41
Company Quality Score 45/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 79.5%

Trading Range & Key Levels

30-Day Trading Range $2.76 - $3.41
Current vs Trading Range SLIGHTLY LOW
Support Level $2.67
Resistance Level $3.21
Current Trend Sideways
Technical data as of Nov 12, 2026

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (50/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-4.8%)
  • BULLISH: Trading 342.2% below Wall St target ($12.25)
  • BULLISH: Market expects only 0% annual growth - appears undervalued
  • WARNING: Composite score 45/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -184.67
Wall Street Target $12.25 (+342.2%)
Revenue Growth (YoY) -100.0%
Profit Margin -115.5%
PE vs Historical -184.7 vs 83.6 CHEAP
Share EVAX Analysis

Share this live EVAX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (EVAX)

Bullish 1 Retail Mentions
Reddit / WSB Comments
1
Bullish
Last Tracked
Jan 15, 2022
Daily AI digest
AI Retail Discussion Summary: Reddit & WallStreetBets discussions on EVAX are bullish (sentiment score +0.38) across 1 tracked comments.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:44 AM ET
Data refreshes hourly during market hours. Next update: 6:44 AM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for EVAX.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
REGN
Regeneron Pharmaceuticalâ€Ļ
BUY
28 analysts
$978 32 SELL
PRAX
Praxis Precision Medicinâ€Ļ
STRONG BUY
21 analysts
$650 32 SELL
JAZZ
Jazz Pharmaceuticals PLC
STRONG BUY
22 analysts
$296 24 SELL
DYN
Dyne Therapeutics Inc
STRONG BUY
17 analysts
$34 49 HOLD
ACAD
ACADIA Pharmaceuticals Iâ€Ļ
STRONG BUY
20 analysts
$31 48 HOLD

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive EVAX Research Pages
EVAX Technical Chart EVAX Price Prediction EVAX Intrinsic Value DCF EVAX Earnings Date EVAX Investment Advisor EVAX Fair Price Analyzer EVAX Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals